NFKB1 and amyotrophic lateral sclerosis: Moreover, although fibroblasts from ALS patients with no known ALS variants (uvALS) do not show significant differences in both total and p-NF-κB levels compared to controls, fibroblasts carrying the C9orf72 expansions display increased total and activated NF-κB (Fig. 1).